Publications: Dr Alina Chakraborty
Biswas B, Guemiri R, Cadix M, Labbé CM, Chakraborty A, Dutertre M, Robert C, Vagner S
(
2022
)
.
Differential Effects on the Translation of Immune-Related Alternatively Polyadenylated mRNAs in Melanoma and T Cells by eIF4A Inhibition
.
Cancers (Basel)
vol.
14
,
(
5
)
Fabbri L, Chakraborty A, Robert C, Vagner S
(
2021
)
.
The plasticity of mRNA translation during cancer progression and therapy resistance
.
Nat Rev Cancer
vol.
21
,
(
9
)
558
-
577
.
Saulnier O, Guedri-Idjouadiene K, Aynaud M-M, Chakraborty A, Bruyr J, Pineau J, O'Grady T, Mirabeau O et al.
(
2021
)
.
ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion
.
Nucleic Acids Res
vol.
49
,
(
9
)
5038
-
5056
.
Tanaka I, Chakraborty A, Saulnier O, Benoit-Pilven C, Vacher S, Labiod D, Lam EWF, Bièche I et al.
(
2020
)
.
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
.
Nucleic Acids Res
vol.
48
,
(
5
)
2676
-
2693
.
Chakraborty A, Mukherjee S, Saha S, De S, Sengupta Bandyopadhyay S
(
2017
)
.
Phorbol-12-myristate-13-acetate-mediated stabilization of leukemia inhibitory factor (lif) mRNA: involvement of Nucleolin and PCBP1
.
Biochem J
vol.
474
,
(
14
)
2349
-
2363
.
Saha S, Chakraborty A, Bandyopadhyay SS
(
2016
)
.
Stabilization of Oncostatin-M mRNA by Binding of Nucleolin to a GC-Rich Element in Its 3'UTR
.
J Cell Biochem
vol.
117
,
(
4
)
988
-
999
.